Please login to the form below

Memorial Sloan Kettering

This page shows the latest Memorial Sloan Kettering news and features for those working in and with pharma, biotech and healthcare.

Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal

For OSE, the deal gives it another partnership with a large pharma partner, adding to collaborations with Memorial Sloan Kettering Cancer Centre in the US and biotech Selexis on immuno-oncology,

Latest news

Gilead adds to CAR-T assets with Cell Design Labs buyout

It’s an exciting time, ”said Renier Brentjens, medical oncologist and director of cellular therapeutics at Memorial Sloan Kettering Cancer Centre.
Keytruda claims first blood cancer OK from FDA

fight against this devastating disease," said Craig Moskowitz, clinical director of the division of haematologic oncology, Memorial Sloan Kettering Cancer Centre in the US.
Takeda launches drug discovery biotech

It builds on work from the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) - a partnership created in 2013 by the Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill ... We're tapping into the distinguished talent
Wearables' impact on cancer patients' quality of life to be tested

Project sees the Memorial Sloan Kettering Cancer Center collaborate with Medidata. ... The Memorial Sloan Kettering Cancer Center (MSK) is collaborating with cloud-based research solutions firm Medidata on the project, which will test the use of activity
Trial of AbbVie's Rova-T disappoints at ASCO

Lead investigator Charles Rudin from Memorial Sloan Kettering Cancer Centre said this is the first time that a biomarker has been able to predict whether a drug will be effective in

More from news
Approximately 1 fully matching, plus 22 partially matching documents found.

Latest Intelligence

Deal Watch September 2016

No other financial details were disclosed. Fate Therapeutics entered a three year arrangement with Memorial Sloan Kettering Cancer Center to use engineered pluripotent cell lines to develop T cell product candidates.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Lilly appoints Maura Dickler as VP of late phase oncology development

She will join the pharma firm from the Memorial Sloan Kettering Cancer Center. ... She will move to the pharmaceutical company from the prestigious Memorial Sloan Kettering Cancer Center, where she currently serves as associate member, Breast Medicine
José Baselga joins BMS’ board of directors

Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and
OncoMed’s CMO steps down

Prior to this, Dr Dupont was director of early and late stage development at Genentech, and served as a researcher in tumour immunology at the Memorial Sloan Kettering Cancer Center.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Getting personal with wearable tech

In July 2016, a prestigious US cancer centre, The Memorial Sloan Kettering Cancer Center (MSK), announced their plans to evaluate wearables and other mobile technology to assess cancer patients' quality of

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Medical Writer: Great salary and benefits

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Account Manager – Med Comms – London: Salary TBC

Senior Account Manager / Account Director: Great salary and bebefits

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Programme Executive: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior Account Manager or AD - Medical Communications: Salary TBC

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Medical Writer: Great salary and bebefits

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Scientific Director: Great salary and bebefits

Subscribe to our email news alerts

PMHub

Add my company

3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

Pharma’s isolated islands of innovation: With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit: What does it mean for the life science sector?...
The Holy Grail of HCP Access: This is the data you need to gain access....